• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

jmcauley@unimelb.edu.au

Credentials


Position
Senior Research Fellow
Department of Microbiology and Immunology
Education
Post Doctorate
St Jude Children's Research Hospital
Bachelors Degree
Swinburne University of Technology
Bachelors Degree (Honours)
Swinburne University of Technology
PhD
The University of Queensland
ORCID

0000-0003-2493-3465

Dr Julie McAuley

Senior Research Fellow
Department of Microbiology and Immunology

61 Scholarly works
28 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Inhibition of influenza virus infection by garlic oil and juice in cell culture
    DOI: 10.1002/jsf2.70042
  • 2025

    Journal article

    Air–Liquid-Interface-Differentiated Human Nose Epithelium: The Benchmark Culture Model for SARS-CoV-2 Infection
    DOI: 10.3390/organoids4030021
  • 2025

    Journal article

    Spectroscopic Characterization and Differentiation of SARS-CoV-2 Virus-like Particles
    DOI: 10.1021/acs.analchem.5c01859
  • 2025

    Book Chapter

    Polarized Calu-3 Cells Serve as an Intermediary Model for SARS-CoV-2 Infection.
    DOI: 10.1007/7651_2024_602
  • 2024

    Research contracts (non-grants)

    Testing Flu Antivirals
  • 2023

    Research grants (ARC, NHMRC, MRFF)

    RNA Powered Antiviral Antibodies
  • 2022

    Research Grant

    Pre-Clinical Testing of Novel Inhaled RNA Therapies for Stability, Safety and Effectiveness Against SARS-CoV-2 to Demonstrate Proof of Concept
Julie McAuley

RECENT SCHOLARLY WORKS

  • 2024

    Journal article

    mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
    DOI: 10.1016/j.omtm.2024.101380
  • 2024

    Journal article

    Inhibitory effects of SARS-CoV-2 penetration of host cells by garlic oil and juice extract are cultivar specific
    DOI: 10.1016/j.jff.2024.106393
  • 2024

    Journal article

    Uncovering strain- and age-dependent innate immune responses to SARS-CoV-2 infection in air-liquid-interface cultured nasal epithelia
    DOI: 10.1016/j.isci.2024.110009
  • 2024

    Journal article

    Human Nasal Epithelium Organoids for Assessing Neutralizing Antibodies to a Protective SARS-CoV-2 Virus-like Particle Vaccine
    DOI: 10.3390/organoids3010002
  • 2024

    Journal article

    Optimization of Reverse Transcription Loop-Mediated Isothermal Amplification for In Situ Detection of SARS-CoV-2 in a Micro-Air-Filtration Device Format
    DOI: 10.1021/acsomega.4c05784
  • 2023

    Journal article

    SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates
    DOI: 10.1073/pnas.2301689120

RECENT PROJECTS

  • 2025

    Research contracts (non-grants)

    Effectiveness of Prototypic siRNA Antiviral Candidates Against SARS-CoV-2 Infection
  • 2024

    Research contracts (non-grants)

    Sensitivity of Rapid Antigen Tests

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224